Warhound launches with $200 million to genetically enhance military dogs with Anduril tech

A defense startup built around dogs

A new Texas-based defense startup called Warhound has raised $200 million to pursue a plan that combines genetic engineering with military hardware: produce healthier, more capable working dogs for the US military and police, then equip them with Anduril's technology. According to The Verge, the company was conceived by Palmer Luckey, the founder of Anduril, and Ben Lamm, co-founder of Colossal Biosciences, the company known for its work on resurrecting extinct animals.

"Man's best friend deserves man's best tech," Luckey said in the announcement, though Bloomberg reports that while he helped conceive the venture, he holds no equity and has no ongoing role in it. Warhound is led by CEO David Spirk, a Marine veteran and intelligence specialist, who framed the goal as delivering "healthier dogs, better-prepared teams, and more service members and first responders coming home safely."

Editing genes for the job

Warhound intends to draw on Colossal's work in genetics, cloning and animal biology to produce dogs with characteristics suited to demanding missions. In a statement to TechCrunch, Lamm said the plan is to edit out health problems such as poor eyesight and a greater likelihood of cancer, while introducing genes that boost speed and agility and sharpen olfactory sensing, the last of which is aimed at detection tasks like bomb sniffing. The company's research starts with breeds commonly used for working roles, such as the Belgian Malinois and German Shepherd, but its stated ambition is to create what it calls "a new type of dog."

Anduril hardware on top

The second half of the formula belongs to Anduril. The Verge reports that the dogs would be fitted with the defense contractor's "advanced cybernetic Augments," including eye and ear protection plus EagleEye military technology, intended to give both the animals and their handlers greater awareness and protection in the field.

A procurement problem driving the pitch

The commercial case rests on how the US currently sources its working dogs. According to The Verge, 80 percent of US military dogs come from Europe, and the company's press release says that fewer than half of the dogs procured overseas typically prove fit for service after a roughly three-year acquisition-and-training pipeline. Warhound's argument is that domestically bred, genetically optimized dogs could raise that success rate while reducing dependence on foreign suppliers.

Nothing to deploy yet

For now, the dogs do not exist. The Verge notes that if and when they are produced, Warhound expects them to serve in elite roles within US military forces, emergency first-response teams and law enforcement. The American Humane Society will advise the company and certify its training programs.

Why it matters

Warhound sits at the junction of two of the most heavily funded corners of the tech industry: defense hardware and synthetic biology. Anduril, best known for drones, sensors and autonomous systems, would extend its reach onto living, engineered animals, while Colossal's gene-editing expertise would find an applied market far from conservation. The procurement figures explain the seriousness of the pitch: sourcing four out of five military dogs from abroad, then losing more than half of them over a three-year training pipeline, is an expensive bottleneck. Whether gene-edited working dogs are scientifically and ethically viable at scale is entirely unproven, and Warhound faces a long research runway before it delivers a single animal. Still, the launch signals that defense procurement, rather than consumer or conservation uses, may become a serious proving ground for genetic engineering.